Likewise, there has been an increased focus on NPTX2, which has been highlighted as a prominent biomarker, partly due to its expression in AD‐affected regions in the brain50 as well as its involvement in synaptic plasticity20, 21 and significant changes in multiple neurodegenerative disorders.16 The gene discussed is NPTX2; the disease is Alzheimer disease.